ALEBUND-B
09637ALEBUND-B (09637)
Alebund Pharmaceuticals (Jiangsu) Limited operates as a biopharmaceutical company that develops therapies for kidney diseases and their complications in China a...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- Global Report · 18 hours ago
Biotech Firms Push Weight-Loss and AI Pipelines Amid Buyback Wave
- Zhitong · 1 day ago, 10:24 AM
ALEBUND-B's public offering received nearly a thousand times subscription and will be listed on the Hong Kong Stock Exchange on June 29
- HKEJ · 1 day ago, 05:45 AM
New Stock IPO | 3 stocks will be listed next Monday, Baige Digital's dark market rose 2.7 times
- Tasty Money · 1 day ago, 05:40 AM
【New Stock IPO】【Dark Market/Allocation Results】The biopharmaceutical company ALEBUND-B (9637), which provides kidney disease therapies, rose a maximum of 94.159% in the dark market, with a paper profit of HKD 2,128 for one lot
- AASTOCKS · 1 day ago, 05:35 AM
"New Shares" ALEBUND-B closed at HKD 42.52 in the dark market, 88.1% higher than the listing price
- Zhitong · 1 day ago, 03:36 AM
New Stock Dark Market | ALEBUND-B initially rose 76.99%, with a paper profit of HKD 1,740 for one lot
